Hepatitis A: Clinical Trials

82 trials for Hepatitis A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

59 completed, 7 unknown, 5 not yet recruiting, 5 withdrawn. 32 Phase 4, 21 Phase 3, 6 Phase 2, 5 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 432Completed 23, Unknown 4, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1
Phase 321Completed 16, Unknown 3, Active not recruiting 1, Terminated 1
Phase 26Completed 5, Unknown 1
Not applicable5Completed 2, Withdrawn 2, Not yet recruiting 1
Phase 11Completed 1

Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risk Factors and Outcomes of Hepatitis A in Children
Hepatitis A, Acute Hepatitis
Not yet recruitingAssiut University1902026-09-262026-09-30
Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine
Healive®, Havrix® - Hepatitis A
RecruitingSinovac Biotech Co., Ltd1062026-08-022026-10-22
Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis
Ursodeoxycholic Acid, Supportive Care - Hepatitis A, Hepatitis E Virus Infection
Not applicableNot yet recruitingCombined Military Hospital, Pakistan882026-04-012026-04-13
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
Polio, Measles
Not yet recruitingChina National Biotec Group Company Limited6002026-01-302026-01-14
A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine
Inactivated HAV vaccine, Attenuated live HAV vaccine - Hepatitis A
CompletedSinovac Biotech Co., Ltd1052026-01-132026-10-02
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Immunity With Acute Hepatits A
Hepatitis A, Hepatitis A Virus
Not yet recruitingAssiut University502025-10-012025-04-24
Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents
Hepatitis A, Hepatitis A Virus
Active not recruitingChiang Mai University602025-06-262026-05-22
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
Inactivated hepatitis A vaccine (I-HAV) - Hepatitis A, Hepatitis A Virus
Phase 3Active not recruitingChiang Mai University362025-05-252026-05-22
Phase IV Study of Concomitant Administration of the sIPV and HepA
sIPV (booster dose at 18 months of age), HepA-L, HepA-I - Polio, Hepatitis A
Phase 4Not yet recruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences20002024-06-152024-06-14
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
Mevac-A vaccine, Havrix 720 Junior - HAV, Hepatitis A
Phase 3CompletedChiang Mai University1202024-04-272025-05-04
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
HAVRIX - Cirrhosis, Hep A
Phase 4UnknownMahidol University502024-02-292024-03-19
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
Hepatitis A Vaccine - Hepatitis A
Phase 4UnknownBest Healthcare Inc.3002024-01-012023-12-28
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency
Phase 4CompletedLiuZhou People's Hospital3922023-12-192025-12-31
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
Healive (hepatitis A vacine(human diploid cell), inactivated) - Hepatitis A
Phase 4Active not recruitingSinovac Biotech Co., Ltd10922023-10-242024-08-21
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL - Hepatitis A, Hep A
Phase 3UnknownBoryung Biopharma Co., Ltd.1062022-12-012022-11-14
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
questionnaire - Cirrhosis
CompletedCentre Hospitalier Sud Francilien7422021-09-272026-05-22
What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years
Blood test - Hepatitis A
CompletedUniversity of Lausanne Hospitals502019-10-062022-08-23
Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men
POL arm, Comparison arm - Meningitis, HPV - Anogenital Human Papilloma Virus Infection
Not applicableWithdrawnAnn & Robert H Lurie Children's Hospital of Chicago2018-09-012019-07-23
Seroepidemiology of Viral Hepatitis in Hong Kong
No intervention - Viral Hepatitis
CompletedChinese University of Hong Kong28882018-09-012023-02-08

Showing 20 of 82. Sign in to see all of them.

Narrower conditions

Hepatitis B (23)  ·  Hepatitis (13)  ·  Chickenpox (5)  ·  Measles (5)  ·  Mumps (4)  ·  Rubella (4)  ·  Vaccine-Preventable Diseases (4)  ·  Encephalitis, Japanese (3)  ·  HIV Infections (3)  ·  Poliomyelitis (3)  ·  Whooping Cough (3)  ·  Enterovirus Infections (2)  ·  Fibrosis (2)  ·  Hepatitis C (2)

Broader conditions

Infections (82)  ·  Digestive System Diseases (81)  ·  Hepatitis, Viral, Human (81)  ·  Liver Diseases (81)  ·  Picornaviridae Infections (81)  ·  RNA Virus Infections (81)  ·  Virus Diseases (81)  ·  Enterovirus Infections (80)  ·  Hepatitis (69)  ·  DNA Virus Infections (28)  ·  Blood-Borne Infections (27)  ·  Communicable Diseases (27)  ·  Hepadnaviridae Infections (23)  ·  Bacterial Infections (8)  ·  Bacterial Infections and Mycoses (8)

Interventions

Hepatitis A Vaccines (29)  ·  twinrix (8)  ·  Blood Specimen Collection (6)  ·  Engerix-B (6)  ·  Hepatitis B Vaccines (4)  ·  Chickenpox Vaccine (3)  ·  epaxal berna (3)  ·  Data Collection (2)  ·  Japanese Encephalitis Vaccines (2)  ·  Aging (1)  ·  Community-Institutional Relations (1)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (1)  ·  Fluzone High-Dose (1)  ·  Freeze Drying (1)  ·  Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)

Sponsors

GlaxoSmithKline (27)  ·  Sinovac Biotech Co., Ltd (8)  ·  Sanofi Pasteur, a Sanofi Company (6)  ·  Chiang Mai University (3)  ·  Crucell Holland BV (3)  ·  Assiut University (2)  ·  Centers for Disease Control and Prevention (2)  ·  China National Biotec Group Company Limited (2)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (2)  ·  Aalborg University Hospital (1)  ·  Ain Shams University (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Best Healthcare Inc. (1)

Countries

China (17)  ·  Belgium (15)  ·  Thailand (7)  ·  United States (7)  ·  Czechia (6)  ·  Germany (3)  ·  South Korea (3)  ·  Australia (2)  ·  France (2)  ·  Mexico (2)  ·  Brazil (1)  ·  Cambodia (1)  ·  Canada (1)  ·  Chile (1)  ·  Costa Rica (1)

Top investigators

Natchaya Kunanitthaworn, MD (3)  ·  Tavitiya Sudjaritruk, MD, PhD (3)  ·  Fubao Ma (2)  ·  Ahlam B Ali, prof (1)  ·  Allan Hildesheim, Ph.D. (1)  ·  Amy K Johnson, PhD (1)  ·  Andre Vertruyen, MD (1)  ·  Beth P Bell, MD, MPH (1)  ·  Brian McMahon (1)  ·  Chien-Ching Hung (1)  ·  Christine H Lee, MD (1)  ·  Claude Flamand, Ph.D. (1)

Results publications

PMID 32710245, PMID 21366801, PMID 24508042, PMID 26190091, PMID 11855555, PMID 16708058, PMID 17259872, PMID 17947390, PMID 17980513, PMID 18233994, PMID 20630640, PMID 20856164, PMID 21241735, PMID 22537990, PMID 22777096, PMID 24284413, PMID 24656175, PMID 25483566, PMID 25969561, PMID 26346155, PMID 26770041, PMID 27093164, PMID 27105563, PMID 27686833, PMID 27815383, PMID 28060048, PMID 28319454, PMID 28507927, PMID 28887164, PMID 30030693, PMID 30144521, PMID 30370918, PMID 30673992, PMID 31282539, PMID 32307279, PMID 33110280, PMID 33303216, PMID 33753433, PMID 33990999, PMID 34222044, PMID 37036404, PMID 37243166, PMID 37252544, PMID 37833325, PMID 38138042, PMID 38637212, PMID 39165801, PMID 39810097, PMID 40391688, PMID 7847285

NIH funding

R01AI130398 (1), R01DA017476 (1)